Syncom Formulations (India) Limited (SYNCOMF) — Announcement | 13 August 2026(2 announcements)

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement Neutral 📄 PDF
📢 Key Event
Syncom Formulations announces Q1 FY2026-27 results with 8% revenue growth and 58% PAT increase
🔄 What Changed
Profit after tax up 58% to ₹24.85 crore; revenue from operations up 7% to ₹125.53 crore
💡 Investor Takeaway
The company's growth reflects a sustainable, ethical business model that should support long-term shareholder value.

Syncom Formulations reported strong Q1 FY2026-27 growth with consolidated income rising 8% to ₹133.36 crore and profit after tax increasing 58% to ₹24.85 crore, driven by its ethical prescription-led model and expanding domestic and international operations. The Board recommended a ₹0.10 per share dividend pending shareholder approval at the AGM.

2 Announcement Neutral 📄 PDF
📢 Key Event
Resignation of Managing Director effective August 11, 2026
💡 Investor Takeaway
The leadership change may affect short-term execution but is framed as a planned succession.

Syncom Formulations disclosed the resignation of Managing Director Vijay Shankarlal Bankda effective August 11, 2026, following a leadership transition and succession planning process, with the resignation received by the company on August 8, 2026 at 2:35 PM.

About Syncom Formulations (India) Limited (SYNCOMF)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹2,010.66 Cr P/E: 23.5 ROE: 25.0% ROCE: 32.9%

View full SYNCOMF stock details →

📡 Get AI alerts when SYNCOMF files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SYNCOMF — Free

📊 More SYNCOMF filings

See all SYNCOMF filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SYNCOMF files new disclosures

Track SYNCOMF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SYNCOMF — Free

Free account · 2 AI queries/day